1. A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters
   Hyun-Jin Kang et al, 2016, Journal of the American Chemical Society CrossRef
2. Telomerase Is a Highly Sensitive and Specific Molecular Marker in Fine-Needle Aspirates of Breast Lesions
   Christopher Poremba et al, 1999, Journal of Clinical Oncology CrossRef
3. Telomerase Activity and Prognosis in Primary Breast Cancers
   Lisa A. Carey et al, 1999, Journal of Clinical Oncology CrossRef
4. Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer
   William C. Hahn, 2003, Journal of Clinical Oncology CrossRef
5. Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths
   Ying-Li Wu et al, 2006, Journal of Cell Science CrossRef
6. Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
   E Hiyama et al, 1997, European Journal of Cancer CrossRef
7. Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders
   Marco Ladetto et al, 2004, Blood CrossRef
8. Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection
   Vjosa A. Zejnullahu et al, 2017, PRILOZI CrossRef
9. High Telomerase RNA Expression Level Is an Adverse Prognostic Factor for Favorable-Histology Wilms' Tumor
   Jeffrey S. Dome et al, 2005, Journal of Clinical Oncology CrossRef
10. Association Between Telomerase Activity and Outcome in Patients With Nonmetastatic Ewing Family of Tumors
    A. Ohali et al, 2003, Journal of Clinical Oncology CrossRef
11. Role of Telomerase in Normal and Cancer Cells
    Matthew Meyerson, 2000, Journal of Clinical Oncology CrossRef
12. Survival Prediction in Patients With Glioblastoma Multiforme by Human Telomerase Genetic Variation
    Luo Wang et al, 2006, Journal of Clinical Oncology CrossRef
13. A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
    Sólrún Melkorka Maggadóttir et al, 2022, Frontiers in Oncology CrossRef
14. Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears
    K Kawai et al, 1998, European Journal of Cancer CrossRef
15. Telomerase Activity Is Increased and Telomere Length Shortened in T Cells from Blood of Patients with Atopic Dermatitis and Psoriasis
    Kaida Wu et al, 2000, The Journal of Immunology CrossRef
16. Cancer Modeling: How Far Can We Go?
    K.G. Manton et al, 2009, Cancer Mortality and Morbidity Patterns in the U.S. Population CrossRef